Latest News

Spinomix closes a $ 3 Million financing round led by Debiopharm Group™

Debiopharm, Immunexpress and Biocartis Announce Collaboration to Advance Development of SeptiCyte® Triage for Managing Sepsis

Debiopharm Group™ and Biocartis embark on a partnership aiming at enhancing personalized medicine

Debiopharm and Neovacs sign License and Equity Agreement for the development fo Neovacs´ anti-TNF-Alpha product